Home/Filings/4/0001493152-17-006778
4//SEC Filing

VBI Vaccines Inc/BC 4

Accession 0001493152-17-006778

CIK 0000764195operating

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 5:57 PM ET

Size

8.5 KB

Accession

0001493152-17-006778

Insider Transaction Report

Form 4
Period: 2017-06-14
CHAWLA SAM
Director
Transactions
  • Exercise/Conversion

    Restricted Stock Units (RSUs)

    2017-06-1412,50025,000 total
    Exp: 2026-06-14Common Shares (12,500 underlying)
  • Exercise/Conversion

    Common Shares, no par value per share

    2017-06-14+12,50025,000 total
Holdings
  • Common Shares, no par value per share

    (indirect: See Footnote)
    6,565,843
Footnotes (3)
  • [F1]Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date.
  • [F2]These shares are held of record by Perceptive Life Sciences Master Fund Ltd. and Titan-Perc Ltd, a related entity. As a Portfolio Manager of Perceptive Advisors LLC, a related entity to Perceptive Life Sciences Master Fund Ltd. and Titan-Perc Ltd, Mr. Chawla has voting and dispositive control over any securities owned of record by Perceptive Life Sciences Master Fund Ltd. and Titan-Perc Ltd.
  • [F3]The restricted stock units vest 1/3 per year over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date.

Documents

1 file

Issuer

VBI Vaccines Inc/BC

CIK 0000764195

Entity typeoperating
IncorporatedBritish Columbia, Canada

Related Parties

1
  • filerCIK 0000764195

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:57 PM ET
Size
8.5 KB